Jean De Serres, MD, MSc, MBA, Chairman of SAB Dr DeSerres holds a MD and M.Sc from University of Montreal and a MBA in bioindustries from UQAM. At the beginning of his carreer, he practiced medicine and was Director of teaching unit at McGill University as well as President of the Quebec College of Family Physicians. He has also acted as Director of Public Health in Hull, QC prior to joining Aventis Behring Canada as Medical Director and then as General Manager. He is now VP Clinical Research and Regulatory Affairs at Draximage (a division of Draxis Specialties Pharmaceuticals Inc
Anthony Man B. Med.Sci, M.D. FRCP Dr. Man holds a degree in biochemistry and a medical degree. He spent many years in academic hospital practice (internal medicine and oncology) and has over 40 scientific publications. During 20 years in international pharmaceutical drug development he has successfully brought more than 10 new molecules to the market, mainly in the area of oncology. Dr. Man currently serves as Chief Executive Officer at Basilea Pharmaceutica AG. a Swiss biopharmaceutical company.
Dr Christian Gygi, MD - Urologist Co-Founder of Med Discovery, graduate of the University of Geneva, Switzerland, he began his Urology training in Professor H.-J. Leisinger's department at the University Hospital CHUV in Lausanne. After spending two years in the Urology department of Idianapolis University in the U.S.A. where he exclusively engaged in research in the field of prostatic carcinoma, he returned to Switzerland to become staff urologist. Dr C. Gygi is member of the American Urology Association and he is involved in different medical boards.
Professor Patrice Jichlinski, MD - Urologist Co-founder of Med Discovery, graduate of the University of Geneva, Switzerland (1979), is associate professor of Urology and Head of the Department of Urology a. i. at CHUV-University Hospital in Lausanne Switzerland. He has a special interest in oncologic and reconstructive surgery in Urology with a special interest for bladder cancer and photodynamic applications in this field, in collaboration with the Swiss Federal Institute of Technology (Prof H. van den Bergh). In addition, he is currently involved in basic and clinical research programs. He is member of many scientific societies (AUA, EAU, ESUR, ASLMS, SPIE…).
Norbert Lange, PhD, MBA Norbert Lange, PhD was born in 1965. After finishing his PhD in Physical Chemistry at University of Göttingen, Germany, in 1996 he joined the Swiss Federal Institute of Technology in Lausanne. Since 2002 he holds a faculty position in the Department of Pharmaceutics and Biopharmaceutics at the Section of Pharmaceutical Sciences at the University of Geneva. His principle interests are in vivo fluorescence imaging, photodynamic therapy and drug formulation.
